Market Research Logo

Global Injectable Drug Delivery Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

Global Injectable Drug Delivery Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

Injectable drug delivery is used for direct introduction of a pharmaceutical drug in body of the patient with the help of a delivery device. The global inject able drug delivery market is expected to rise at a CAGR of 12% during the forecast period 2016-2023. Growth in pharmaceutical and biotechnology industry is contributing to the growth of the global inject able drug delivery market. However, infection associated with needle stick injury is the factor restraining the growth of the global inject able drug delivery market during the forecast period.

Geographically, North America accounted for the largest market share in terms of revenue for inject able drug delivery market in 2016 and the region is expected to dominate the market during the forecast period followed by Europe. The dominance of the region is attributed to technologically advanced healthcare facilities in the countries of the region. However, Asia Pacific is expected to be the fastest growing region for inject able drug delivery market during the forecast period. The highest growth in the region is observed due to enhancing healthcare infrastructure and prevalence of chronic diseases in the region.

The growth in global inject able drug delivery market is also influenced by the presence of major players such as Baxter International (U.S.), Schott AG (Germany), Terumo Corporation (U.S.), Hospira Inc. (U.S.), Sanofi SA (France) etc. The market players adopt some crucial strategies such as product launches, partnerships, mergers & acquisitions etc.to gain competitive advantage.

Global inject able drug delivery market report covers segmentation analysis of type, formulation, therapeutic application, usage pattern and end users. Report further covers segmentsof type which includes device and formulations. Device is expected to dominate the segment during the forecast period owing to rising usage in management and control of various disorders at primary level. Formulation packaging in inject able drug delivery is divided as ampoules, bottles, cartridges and vials. Moreover, therapeutic applications of inject able drug delivery include auto immune diseases, hormonal disorders, oncology, orphan diseases and other applications. Oncology is expected to dominate the segment during the forecast period owing to increasing application of inject able drug delivery in diagnosis and treatment of cancer and diabetes. Furthermore, usage pattern segment of inject able drug delivery can be sub divided as curative care, immunization and others. Also, end users of inject able drug delivery include hospitals, homecare and others (Research institutes, clinical, diagnostic laboratories). Homecare segment is expected to dominate the segment during the forecast period owing to increasing demand for self-injection devices which provides easy administration of drugs at home without medical assistance.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. INJECTABLE DRUG DELIVERY MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS AND TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASED DEMAND FOR SELF INJECTION DEVICES
3.1.2. RISING PREVALENCE OF CHRONIC DISEASES
3.1.3. TECHNOLOGICAL ADVANCEMENTS IN MEDICAL INDUSTRY
3.1.4. NEW PRODUCT LAUNCHES
3.1.5. GROWTH IN BIOLOGICS MARKET
3.2. MARKET RESTRAINTS
3.2.1. INFECTIONS ASSOCIATED WITH NEEDLLESTICK INJURIES
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING DEMAND FOR BIOSIMILAR AND GENERIC INJECTABLES
3.3.2. INCREASING APPLICATIONS OF CONTRACEPTIVE INJECTABLES
3.4. MARKET CHALLENGES
3.4.1. PREFERENCE FOR OTHER MODES OF DRUG DELIVERY
4. MARKET SEGMENTATION
4.1.1. INJECTABLE DRUG DELIVERY MARKET BY TYPE
4.1.2. MARKET DEFINITION AND SCOPE
4.1.3. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.5. OPPORTUNITY MATRIX
4.1.6. MARKET SEGMENTATION
4.1.6.1. GLOBAL DEVICES MARKET
4.1.6.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.1.3. TOP PLAYERS & KEY PRODUCTS
4.1.6.1.4. KEY CONCLUSIONS
4.1.6.2. GLOBAL FORMULATIONS MARKET
4.1.6.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.2.3. TOP PLAYERS & KEY PRODUCTS
4.1.6.2.4. KEY CONCLUSIONS
4.2. INJECTABLE DRUG DELIVERYMARKET BY FORMULATION
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL AMPULES MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL BOTTLES MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL CARTRIDGES MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL VIALS MARKET
4.2.5.4.1. APPLICATION
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.3. INJECTABLE DRUG DELIVERYMARKET BY THERAPEUTIC APPLICATION
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL AUTO IMMUNE DISEASES MARKET
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL HORMONAL DISORDERS MARKET
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. GLOBAL ONCOLOGY MARKET
4.3.5.3.1. APPLICATION
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5. KEY CONCLUSIONS
4.3.5.4. GLOBAL ORPHAN DISEASES MARKET
4.3.5.4.1. APPLICATION
4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.4.5. KEY CONCLUSIONS
4.3.5.5. GLOBAL OTHERS MARKET
4.3.5.5.1. APPLICATION
4.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.5.5. KEY CONCLUSIONS
4.4. INJECTABLE DRUG DELIVERYMARKET BY USAGE PATTERN
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION
4.4.5.1. GLOBAL CURATIVE CARE MARKET
4.4.5.1.1. APPLICATION
4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.1.5. KEY CONCLUSIONS
4.4.5.2. GLOBAL IMMUNIZATION MARKET
4.4.5.2.1. APPLICATION
4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.2.5. KEY CONCLUSIONS
4.4.5.3. GLOBAL OTHERS MARKET
4.4.5.3.1. APPLICATION
4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.3.5. KEY CONCLUSIONS
4.5. INJECTABLE DRUG DELIVERYMARKET BY END USER
4.5.1. MARKET DEFINITION AND SCOPE
4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.5.4. OPPORTUNITY MATRIX
4.5.5. MARKET SEGMENTATION
4.5.5.1. GLOBAL HOSPITALS MARKET
4.5.5.1.1. APPLICATION
4.5.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.1.5. KEY CONCLUSIONS
4.5.5.2. GLOBAL HOMECARE MARKET
4.5.5.2.1. APPLICATION
4.5.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.2.5. KEY CONCLUSIONS
4.5.5.3. GLOBAL OTHERS (RESEARCH INSTITUTES, CLINICAL, DIAGNOSTIC LABORATORIES) MARKET
4.5.5.3.1. APPLICATION
4.5.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.5.5.3.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL INJECTABLE DRUG DELIVERYMARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. BECTON DICKINSON AND COMPANY (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. BAXTER INTERNATIONAL (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. PFIZER (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. GERRESHEIMER AG (GERMANY)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. SCHOTT AG (GERMANY)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. ELI LILLY AND COMPANY (U.S.)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. TERUMO CORPORATION (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. ANTARES PHARMA INC. (U.S.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. HOSPIRA INC. (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. NONO NORDISK (DENMARK)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. SANOFI SA (FRANCE)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. SCANDINAVIAN HEALTH LTD. (TAIWAN)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. TERUMO CORPORATION (JAPAN)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. UNILIFE CORPORATION (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. ZOGENIX INC. (U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL INJECTABLE DRUG DELIVERY MARKET BY TYPE ($ MILLION)
GLOBAL DEVICES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL FORMULATIONS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL INJECTABLE DRUG DELIVERY MARKET BY FORMULATION($ MILLION)
GLOBAL AMPULES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL BOTTLES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL CARTRIDGES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL VIALS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL INJECTABLE DRUG DELIVERY MARKET BY THERAPEUTIC APPLICATION ($ MILLION)
GLOBAL AUTO IMMUNE DISEASES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HORMONAL DISORDERS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL ONCOLOGY MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL ORPHAN DISEASES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL OTHERS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL INJECTABLE DRUG DELIVERY MARKET BY USAGE PATTERN($ MILLION)
GLOBAL CURATIVE CARE MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL IMMUNIZATION MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL OTHERS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL INJECTABLE DRUG DELIVERY MARKET BY END USER ($ MILLION)
GLOBAL HOSPITALS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HOMECARE MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL OTHERS (RESEARCH INSTITUTES, CLINICAL, DIAGNOSTIC LABORATORIES) MARKET BY GEOGRAPHY ($ MILLION)
NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
EUROPE INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
REST OF THE WORLD INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
GLOBAL DEVICES MARKET ($ MILLION)
GLOBAL FORMULATIONS MARKET ($ MILLION)
GLOBAL AMPULES MARKET ($ MILLION)
GLOBAL BOTTLES MARKET ($ MILLION)
GLOBAL CARTRIDGES MARKET ($ MILLION)
GLOBAL VIALS MARKET ($ MILLION)
GLOBAL AUTO IMMUNE DISEASES MARKET ($ MILLION)
GLOBAL HORMONAL DISORDERS MARKET ($ MILLION)
GLOBAL ONCOLOGY MARKET ($ MILLION)
GLOBAL ORPHAN DISEASES MARKET ($ MILLION)
GLOBAL OTHERS MARKET ($ MILLION)
GLOBAL CURATIVE CARE MARKET ($ MILLION)
GLOBAL IMMUNIZATION MARKET ($ MILLION)
GLOBAL OTHERS MARKET ($ MILLION)
GLOBAL HOSPITALS MARKET ($ MILLION)
GLOBAL HOMECARE MARKET ($ MILLION)
GLOBAL OTHERS (RESEARCH INSTITUTES, CLINICAL, DIAGNOSTIC LABORATORIES) MARKET ($ MILLION)
UNITED STATES (U.S.) INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
CANADA INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
UNITED KINGDOM (UK) INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
FRANCE INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
GERMANY INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
SPAIN INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
ROE INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
INDIA INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
CHINA INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
JAPAN INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
AUSTRALIA INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
ROAPAC INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET ($ MILLION)
MENA INJECTABLE DRUG DELIVERY MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report